Corcept Therapeutics Incorporated Income Statement
CORT / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Corcept Therapeutics Incorporated reported $761M in revenue and $100M in net income for FY2025. Revenue has grown at a 60.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $761.4M | $675.0M | $482.4M | $401.9M | $366.0M | $353.9M | $159.2M | $81.3M | $159.2M | $26.6M | $50.3M | $3.3M | $3.3M | $3.3M | $1.0M |
| Cost of Revenue | $13.0M | $10.9M | $6.5M | $5.4M | $5.3M | $5.6M | $3.6M | $2.1M | $3.6M | $882.0K | $1.4M | $91.0K | $91.0K | $91.0K | - |
| Gross Profit | - | - | - | - | - | - | $63.6M | $56.5M | $27.0M | $15.7M | $9.8M | $4.2M | $1.7M | $827.0K | - |
| SG&A Expense | $448.7M | $280.3M | $184.3M | $152.8M | $122.4M | $105.3M | $62.4M | $45.2M | $62.4M | $34.9M | $36.9M | $25.4M | $11.3M | $25.4M | $11.3M |
| R&D Expense | $254.9M | $246.9M | $184.4M | $131.0M | $113.9M | $114.8M | $40.4M | $23.8M | $40.4M | $18.4M | $15.4M | $14.1M | $21.0M | $14.1M | $21.0M |
| Operating Income | $44.8M | $137.0M | $107.3M | $112.6M | $124.5M | $128.2M | $52.9M | $10.2M | $52.9M | -$27.6M | -$3.4M | -$36.3M | -$32.3M | -$36.3M | -$32.3M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.7M | - |
| Income Tax | -$33.2M | $20.3M | $18.4M | $14.8M | $12.5M | $25.6M | -$76.3M | $0 | -$76.3M | $0 | $0 | - | - | - | - |
| Net Income | $99.7M | $141.2M | $106.1M | $101.4M | $112.5M | $106.0M | $129.1M | $8.1M | $129.1M | -$31.4M | -$6.4M | -$38.0M | -$32.4M | -$38.0M | -$32.4M |
| EPS (Basic) | $0.95 | $1.35 | $1.02 | $0.95 | $0.97 | $0.92 | $1.14 | $0.07 | -$0.06 | - | - | - | - | - | - |
| EPS (Diluted) | $0.82 | $1.23 | $0.94 | $0.87 | $0.89 | $0.85 | $1.04 | $0.07 | -$0.06 | -$0.31 | -$0.46 | -$0.41 | -$0.39 | -$0.38 | -$0.38 |
| Shares Outstanding | 120.0M | 105.1M | 103.4M | 107.8M | 105.9M | 116.7M | 115.0M | 114.7M | 112.7M | 109.6M | 101.4M | 99.8M | 99.8M | 84.2M | 72.4M |
| Gross Margin | - | - | - | - | - | - | 39.9% | 69.5% | 16.9% | 59.0% | 19.5% | 127.9% | 51.3% | 25.0% | - |
| Operating Margin | 5.9% | 20.3% | 22.2% | 28.0% | 34.0% | 36.2% | 33.2% | 12.5% | 33.2% | -104.0% | -6.9% | -1096.8% | -977.7% | -1096.8% | -3188.6% |
| Profit Margin | 13.1% | 20.9% | 22.0% | 25.2% | 30.7% | 30.0% | 81.1% | 10.0% | 81.1% | -118.2% | -12.7% | -1150.5% | -978.4% | -1150.5% | -3190.7% |